Sponsor pipeline

Vanda Pharmaceuticals clinical trial pipeline

Get alerts when Vanda Pharmaceuticals's trials change

20 active trials 14 recruiting 12 Phase 3 8 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-10-02
critical
NCT05648591 Safety and Tolerability of Open-Labeled Iloperidone in Adolescents · Phase 4
2026-09-25
minor
NCT06830044 Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With… · Phase 3
2026-09-23
minor
NCT07362017 Open Label Study to Investigate the Safety and Efficacy of Ponesimod in… · Phase 3

Active trials by phase

Phase 1
1
Phase 1/2
1
Phase 2
3
Phase 3
12
Phase 4
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT05648591 Safety and Tolerability of Open-Labeled Iloperidone in Adolescents Schizophrenia Recruiting 2026-10-01
Phase 3
NCT06830044 Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With… Major Depressive Disorder (MDD) Recruiting 2026-09-24
NCT07362017 Open Label Study to Investigate the Safety and Efficacy of Ponesimod in… Moderate-to-severe Chronic Plaque Psoriasis Recruiting 2026-09-22
NCT07686081 Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With… Ulcerative Colitis (UC) Recruiting 2026-08-18
NCT06953869 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia Insomnia Disorder Recruiting 2026-06-05
NCT07446439 A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist… Nausea and Vomiting Recruiting 2026-04-20
NCT06961968 Randomized Withdrawal Study in Patients With Schizophrenia Schizophrenia Recruiting 2026-01-12
NCT06836557 Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis Idiopathic Gastroparesis Recruiting 2025-02-20
NCT06701396 Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder… Sleep Wake Disorders Recruiting 2024-11-22
NCT07221578 Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of… Social Anxiety Disorder (SAD) Active, Not Recruiting 2026-08-17
NCT04652882 Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder… Sleep Wake Disorders Active, Not Recruiting 2026-07-27
NCT06138613 Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected… Motion Sickness Active, Not Recruiting 2026-04-16
NCT04326426 ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or… Coronavirus Infection Enrolling by Invitation 2020-04-20
Phase 2
NCT07090161 Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With… Hypertension Recruiting 2026-02-27
NCT07179055 An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in… Dry Eye Recruiting 2025-09-17
NCT07065773 Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe… Onychomycosis of Toenail Active, Not Recruiting 2026-02-04
Phase 1/2
NCT07223632 Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient Charcot Marie Tooth Disease (CMT) Active, Not Recruiting 2026-08-19
Phase 1
NCT03838926 Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic… Relapsed or Refractory Hematologic Malignancies Recruiting 2026-03-16
Not specified
NCT03154697 Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep… Sleep Disturbances in Smith-Magenis Syndrome Recruiting 2024-03-20
NCT01195558 Patient Registry of Blind Subjects With Sleep-related Problems Sleep-wake Disorder in Blind Individuals Recruiting 2020-06-24

Disease areas by active trials

Get alerts when Vanda Pharmaceuticals's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free